Electrospun Type 1 Collagen Matrices Using a Novel Benign Solvent for Cardiac Tissue Engineering

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Polymer Science

Background:

• Electrospinning fabricates fibrous scaffolds mimicking cellular microenvironments.
• Collagen is a preferred biopolymer for its biocompatibility.
• Conventional collagen electrospinning uses toxic solvents like HFIP and TFE.

Purpose of the Study:

• To develop a novel, benign binary solvent for electrospinning Collagen type 1.
• To confirm the structural integrity and biocompatibility of collagen nanofibers.
• To assess the potential for muscle tissue engineering.

Main Methods:

• Electrospinning of Collagen type 1 using a novel benign solvent.
• Transmission Electron Microscopy (TEM) for structural analysis (67 nm banding pattern).
• Scanning Electron Microscopy (SEM) for fiber diameter measurement (200-800 nm).
• MTT assays and confocal microscopy for biocompatibility assessment.
• Culturing neonatal rat ventricular cardiomyocytes on scaffolds.

Main Results:

• Successfully electrospun Collagen type 1 nanofibers using a non-toxic, economical solvent.
• TEM confirmed the native collagen 67 nm banding pattern, indicating preserved triple helical structure.
• SEM showed fiber diameters ranging from 200-800 nm.
• Scaffolds demonstrated excellent biocompatibility with skeletal myoblasts.
• Cardiomyocytes maintained contractile function for 17 days on the scaffolds.

Conclusions:

• Collagen type 1 can be electrospun into functional nanofibers using a novel benign solvent.
• This method avoids toxic solvents and preserves collagen's native structure.
• The developed scaffolds show significant promise for cardiac and skeletal muscle tissue engineering.